This is certainly very strange, given the trial has been unblinded and has no protocol that I know of which would interfere with placebo arm crossover. If this OS benefit were as great as claimed, you would suspect that they would have crossed placebo patients over by now.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.